Bookmark
Forward
Orbital floor triamcinolone causing Cushing's syndrome in a patient treated with Kaletra for HIV 1.
Hannah Zelie Ruth McConkey, Helen Williams, Ranjababu Kulasegaram, Elizabeth Graham
BMJ case reports 2013 Feb 25Sizes of these terms reflect their relevance to your search.
We report the first known case of iatrogenic cushingoid features following orbital floor triamcinolone, a synthetic corticosteroid, in a patient taking Kaletra (200 mg lopinavir/50 mg ritonavir) twice daily and Truvada (tenofovir/emtricitabine) once daily for HIV 1. Previous reports have included similar findings following epidural triamcinolone injections and with inhaled fluticasone.
Citation
Hannah Zelie Ruth McConkey, Helen Williams, Ranjababu Kulasegaram, Elizabeth Graham. Orbital floor triamcinolone causing Cushing's syndrome in a patient treated with Kaletra for HIV 1. BMJ case reports. 2013 Feb 25;2013
Mesh Tags
Substances
PMID: 23440982
View Full Text
